Literature DB >> 17265782

Role of chemotherapy for palliation in the lung cancer patient.

Shannon Stinnett1, Laura Williams, David H Johnson.   

Abstract

Lung cancer is the leading cause of cancer-related deaths in the United States and presents with a constellation of common, often persistent, and severe symptoms. Chemotherapy is well known to impart a survival benefit; however, the benefit of chemotherapy for relief of lung cancer symptoms has been slow to gain recognition. Tumor-related symptoms such as pain, cough, and dyspnea are improved, along with constitutional symptoms such as fatigue and overall quality of life, sometimes even after failure of previous regimens. The efficacy of chemotherapy for the relief of symptoms and improvement in quality of life makes these drugs a fundamental part of palliative care.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17265782

Source DB:  PubMed          Journal:  J Support Oncol        ISSN: 1544-6794


  3 in total

1.  Active treatment given in the last weeks of life: poor quality cancer care or justifiable behavior?

Authors:  Gianmauro Numico; Antonio Trogu; Antonella Cristofano; Alessandro Mozzicafreddo; Giulia Courthod; Pierfrancesco Franco; Nicola Silvestris
Journal:  Support Care Cancer       Date:  2014-05-11       Impact factor: 3.603

2.  Glasgow prognostic score in patients receiving chemotherapy for non-small-cell lung cancer in stages IIIb and IV.

Authors:  Sefika Umihanic; Sekib Umihanic; Sead Jamakosmanovic; Selmira Brkic; Munevera Osmic; Suvad Dedic; Nusret Ramic
Journal:  Med Arch       Date:  2014

3.  Effectiveness of palliative care for non-small cell lung cancer.

Authors:  Huiqin Li; Jianing Li
Journal:  Exp Ther Med       Date:  2016-08-25       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.